FUROSEMIDE SODIUM
Furosemide sodium offers similar diuretic action with improved solubility. Side effects include electrolyte loss, hypotension, and dizziness. Only GMP materials will be supplied, logistics all according to GDP.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
Furosemide sodium is a watersoluble salt form of furosemide, retaining full inhibition of the NaK2Cl cotransporter in the loop of Henle. The sodium salt improves solubility for injectable and concentrated formulations while maintaining potent loopdiuretic activity.
Benefits and Advantages
Used in parenteral formulation research, highsolubility diuretic studies, rapidonset diuresis modelling and NKCC2target assays.
Side Effects and Risks
Similar to furosemide: electrolyte depletion, dehydration, ototoxicity and hypotension. Handle with loopdiuretic precautions and careful doseresponse evaluation.
Only GMP materials will be supplied, logistics all according to GDP.
Datasheet
| Molecular Formula | C12H10ClN2O5SNa |
|---|---|
| Molecular Weight | 352.73 g/mol |
| CAS Number | 41733-55-5 |
| Storage Condition | Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light. |
| Solubility | Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance. |
| Purity | Purity information is available upon request (COA). |
| Synonym | Furosemide sodium; Sodium furosemide; 41733-55-5; Frosemide sodium; UNII-101EM454S7 |
| IUPAC/Chemical Name | sodium 4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoate |
| InChl Key | DLFCAVBMDSKMEY-UHFFFAOYSA-M |
| InChl Code | InChI=1S/C12H11ClN2O5S.Na/c13-9-5-10(15-6-7-2-1-3-20-7)8(12(16)17)4-11(9)21(14,18)19;/h1-5,15H,6H2,(H,16,17)(H2,14,18,19);/q;+1/p-1 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

